BioLife Solutions (BLFS) Proxy Filing summary

Executive summary

• Delivered an investor presentation on July 26, 2024, outlining key governance and control initiatives for the upcoming annual meeting.

• Forward-looking statements highlight ongoing risks and uncertainties, with a commitment to update controls and compliance measures.

• Emphasis on the importance of reading all proxy materials and related filings for informed voting decisions.

Voting matters and shareholder proposals

• Proxy materials and additional information were distributed in connection with the 2024 Annual Meeting.

• Shareholders are encouraged to review all proxy documents before voting.

Board of directors and corporate governance

• Board and management receive monthly SOX updates, with CEO/CFO holding quarterly townhalls to stress control importance.

• Joydeep Goswami attended slightly less than 75% of meetings in 2023 due to external commitments but provided feedback outside meetings; achieved 100% attendance in 2024.

• All directors had 100% attendance in 2021 and over 75% in 2022.